Development of a new permeability assay using low‐efflux MDCKII cells
Top Cited Papers
- 1 November 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 100 (11), 4974-4985
- https://doi.org/10.1002/jps.22674
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P‐glycoprotein in various biological samplesRapid Communications in Mass Spectrometry, 2011
- Comparison of in vitro cell models in predicting in vivo brain entry of drugsInternational Journal of Pharmaceutics, 2010
- The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discoveryNature Reviews Drug Discovery, 2010
- Differences in the expression of endogenous efflux transporters in MDR1‐transfected versus wildtype cell lines affect P‐glycoprotein mediated drug transportBritish Journal of Pharmacology, 2010
- The Effect of Breast Cancer Resistance Protein and P-Glycoprotein on the Brain Penetration of Flavopiridol, Imatinib Mesylate (Gleevec), Prazosin, and 2-Methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic Acid (PF-407288) in MiceDrug Metabolism and Disposition, 2009
- Biopharmaceutics Classification System: Validation and Learnings of an in Vitro Permeability AssayMolecular Pharmaceutics, 2008
- Evaluation of in vitro brain penetration: Optimized PAMPA and MDCKII-MDR1 assay comparisonInternational Journal of Pharmaceutics, 2007
- Animal data: The contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivoAdvanced Drug Delivery Reviews, 2007
- MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability ScreeningJournal of Pharmaceutical Sciences, 1999
- Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption ProcessesJournal of Medicinal Chemistry, 1998